Global Information
회사소개 | 문의

오소바이오로직스 시장 분석과 예측 : 제품별, 용도별, 최종사용자별, 지역별

Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use, And Segment Forecasts, 2014 - 2025

리서치사 Grand View Research, Inc.
발행일 2017년 01월 상품 코드 447156
페이지 정보 영문 100 Pages
가격
US $ 5,950 ₩ 6,622,900 Unprintable PDF by E-mail (Single User License)
US $ 7,950 ₩ 8,849,100 PDF by E-mail (5-User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 2명에서 5명까지 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 9,950 ₩ 11,075,300 PDF by E-mail (Enterprise License) help
동일기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



오소바이오로직스 시장 분석과 예측 : 제품별, 용도별, 최종사용자별, 지역별 Orthobiologics Market Analysis By Product (DBM, Allograft, BMP, Viscosupplementation, Synthetic Bone Substitutes, Stem Cell), By Application (Spinal Fusion, Reconstructive Surgery, Trauma Repair), By End Use, And Segment Forecasts, 2014 - 2025
발행일: 2017년 01월 페이지 정보 : 영문 100 Pages

한글목차

세계의 오소바이오로직스(Orthobiologics) 시장에 대해 조사했으며, 제품, 용도, 최종사용자, 지역별 시장 동향 및 시장 점유율 분석·예측, 시장 촉진·억제요인, SWOT 분석, 시장의 매력도·Porter의 산업 분석, 경쟁 구도 및 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 조사 방법과 조사 범위

제2장 개요

제3장 오소바이오로직스 시장 : 동향과 범위

  • 시장 세분화와 시장 범위
  • 시장 촉진요인
  • 시장 억제요인
  • 침투도·성장 전망 지도제작
  • SWOT 분석
  • Porter의 산업 분석

제4장 오소바이오로직스 시장 : 제품별

  • 오소바이오로직스 시장 : 제품 분석
  • 탈회골기질(DBM)
    • 탈회골기질(DBM) 시장 예측
  • 동종골이식편
    • 동종골이식편 시장 예측
  • 뼈형성 단백질(BMP)
    • 뼈형성 단백질(BMP) 시장 예측
  • 관절액 보충약
    • 관절액 보충약 시장 예측
  • 합성 골이식 대체물
    • 합성 골이식 대체물 시장 예측
  • 줄기세포 요법
    • 줄기세포 요법 시장 예측

제5장 오소바이오로직스 시장 : 용도별

  • 오소바이오로직스 시장 : 용도 분석
  • 척추 고정 수술
    • 척추 고정 수술 시장 예측
  • 재건 수술
    • 재건 수술 시장 예측
  • 외상 수술
    • 외상 수술 시장 예측

제6장 오소바이오로직스 시장 : 최종사용자별

  • 오소바이오로직스 시장 : 최종사용자 분석
  • 병원
  • 접골원

제7장 오소바이오로직스 시장 : 지역별

  • 오소바이오로직스 시장 : 지역별 시장 점유율
  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동·아프리카

제8장 경쟁 구도

  • 전략 프레임워크
  • 시장 참여 카테고리
  • 기업 개요
KSA 17.03.06

영문목차

The global orthobiologics market is expected to reach USD 10.2 billion by 2025, according to a new study by Grand View Research, Inc. The orthobiologics market is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.

These advancements are accompanied with the benefits such as enhanced biocompatibility, reduced surgical time and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which in turn is expected to boost the orthobiologics market during the forecast period.

Further Key Findings From the Study Suggest:

  • In 2015, viscosupplementation accounted for the largest share in the product segment owing to being a cost efficient therapeutic alternative for symptomatic management of osteoarthritis
  • Spinal fusion held the largest share in the application segment in 2015, owing to presence of third party insurers and reimbursement structure for fusion enhancement products thus triggering growth
  • In 2015, North America accounted for the dominant share owing to consistent efforts of industry players in promoting awareness pertinent to the orthobiological products resulting in significant rise in adoption rate
  • Asia Pacific is anticipated to exhibit an exponential CAGR as a consequence of significant surge in healthcare spending and awareness levels with respect to the availability of orthobiologics
  • The prominent players are consistently indulging into extensive strategies to gain competitive position including regional expansion and mergers & acquisitions to capture a greater market share
  • For instance, in November 2015, Bioventus acquired BioStructures, a bioabsorbable bone graft developer. This acquisition was carried out to expand orthobiologics product portfolio and grafting solutions in order to expand their market share

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region Wise Market: Base Estimates
    • 1.1.2 Global Market: CAGR Calculation
  • 1.2 Region based segment share calculation
  • 1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Orthobiologics Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
  • 3.2 Market Driver Analysis
  • 3.3 Market Restraint Analysis
  • 3.4 Penetration & growth prospect mapping
  • 3.5 Orthobiologics - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's

Chapter 4 Orthobiologics Market: Product Estimates & Trend Analysis

  • 4.1 Orthobiologics market: Product movement analysis
  • 4.2 Demineralized Bone Matrix (DBM)
    • 4.2.1 DBM market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.3 Allograft
    • 4.3.1 Allograft market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.4 Bone Morphogenetic Protein (BMP)
    • 4.4.1 BMP market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.5 Viscosupplementation
    • 4.5.1 Viscosupplementation market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.6 Synthetic Bone Substitutes
    • 4.6.1 Synthetic bone substitutes market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 4.7 Stem Cell Therapy
    • 4.7.1 Stem cell therapy market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 5 Orthobiologics Market: Application Estimates & Trend Analysis

  • 5.1 Orthobiologics market: Application movement analysis
  • 5.2 Spinal Fusion
    • 5.2.1 Spinal fusion market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 5.3 Trauma Repair
    • 5.3.1 Trauma repair market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 5.4 Reconstructive Surgery
    • 5.4.1 Reconstructive surgery market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 6 Orthobiologics Market: End-use Estimates & Trend Analysis

  • 6.1 Orthobiologics market: End-use movement analysis
  • 6.2 Hospitals
    • 6.2.1 Hospitals market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 6.3 Orthopedic Clinics
    • 6.3.1 Orthopedic clinics market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 7 Orthobiologics: Regional Estimates & Trend Analysis, by Product, Application & End-use

  • 7.1 Orthobiologics market shares by region, 2015 & 2024
  • 7.2 North America
    • 7.2.1 North America orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. orthobiologics market estimates and forecasts, 2014 - 2025(USD Billion)
    • 7.2.3 Canada
      • 7.2.3.1 Canada orthobiologics market estimates and forecasts, 2014 - 2025(USD Billion)
  • 7.3 Europe
    • 7.3.1 Europe orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.3.2 Germany
      • 7.3.2.1 Germany orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.3.3 UK
      • 7.3.3.1 UK orthobiologics market estimates and forecasts, 2014 - 2025(USD Billion)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.4.2 Japan
      • 7.4.2.1 Japan orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.4.3 China
      • 7.4.3.1 China orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.4.4 India
      • 7.4.4.1 India orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 7.5 Latin America
    • 7.5.1 Latin America orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
  • 7.6 MEA
    • 7.6.1 MEA orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa orthobiologics market estimates and forecasts, 2014 - 2025 (USD Billion)

Chapter 8 Competitive Landscape

  • 8.1 Strategy framework
  • 8.2 Market participation categorization
  • 8.3 Company Profiles
    • 8.3.1 Bone Biologics, Corp.
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 Medtronic
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 Bioventus LLC
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 Pioneer Surgical Technology
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 Smith & Nephew plc
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 Stryker Corporation
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 DePuy Synthes, Inc.
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Financial Performance
      • 8.3.7.3 Product Benchmarking
      • 8.3.7.4 Strategic Initiatives
    • 8.3.8 Genzyme
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Financial Performance
      • 8.3.8.3 Product Benchmarking
      • 8.3.8.4 Strategic Initiatives
    • 8.3.9 Osiris Therapeutics, Inc.
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 Globus Medical
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Financial Performance
      • 8.3.10.3 Product Benchmarking
      • 8.3.10.4 Strategic Initiatives
    • 8.3.11 Wright Medical Technology
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives
    • 8.3.12 Orthofix, Inc.
      • 8.3.12.1 Company Overview
      • 8.3.12.2 Financial Performance
      • 8.3.12.3 Product Benchmarking
      • 8.3.12.4 Strategic Initiatives
    • 8.3.13 NuVasive, Inc.
      • 8.3.13.1 Company Overview
      • 8.3.13.2 Financial Performance
      • 8.3.13.3 Product Benchmarking
      • 8.3.13.4 Strategic Initiatives
    • 8.3.14 Zimmer Biomet
      • 8.3.14.1 Company Overview
      • 8.3.14.2 Financial Performance
      • 8.3.14.3 Product Benchmarking
      • 8.3.14.4 Strategic Initiatives
    • 8.3.15 Anthrex
      • 8.3.15.1 Company Overview
      • 8.3.15.2 Financial Performance
      • 8.3.15.3 Product Benchmarking
      • 8.3.15.4 Strategic Initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 3 North America orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 4 North America orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 5 U.S. orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 8 Canada orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 9 Canada orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 10 Canada orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 11 Europe orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 12 Europe orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 13 Europe orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 14 Germany orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 15 Germany orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 16 Germany orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 17 UK orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 18 UK orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 19 UK orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 20 Asia Pacific orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 21 Asia Pacific orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 22 Asia Pacific orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 23 Japan orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 24 Japan orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 25 Japan orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 26 China orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 27 China orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 28 China orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 29 India orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 30 India orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 31 India orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 32 Latin America orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 33 Latin America orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 34 Latin America orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 35 Brazil orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 36 Brazil orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 37 Brazil orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 38 Mexico orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 39 Mexico orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 40 Mexico orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 41 MEA orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 42 MEA orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 43 MEA orthobiologics market, by end-use, 2014 - 2025 (USD Billion)
  • TABLE 44 South Africa orthobiologics market, by product, 2014 - 2025 (USD Billion)
  • TABLE 45 South Africa orthobiologics market, by application, 2014 - 2025 (USD Billion)
  • TABLE 46 South Africa orthobiologics market, by end-use, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market summary (USD Billion)
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Orthobiologics market product outlook key takeaways
  • FIG. 10 Orthobiologics market: Product movement analysis
  • FIG. 11 Global DBM market, 2014 - 2025 (USD Billion)
  • FIG. 12 Global allograft market, 2014 - 2025 (USD Billion)
  • FIG. 13 Global machined bones market, 2014 - 2025 (USD Billion)
  • FIG. 14 Global BMP market, 2014 - 2025 (USD Billion)
  • FIG. 15 Global viscosupplementation market, 2014 - 2025 (USD Billion)
  • FIG. 16 Global synthetic bone substitutes market, 2014 - 2025 (USD Billion)
  • FIG. 17 Global stem cell therapy market, 2014 - 2025 (USD Billion)
  • FIG. 18 Global others market, 2014 - 2025 (USD Billion)
  • FIG. 19 Orthobiologics market application outlook: Key takeaways
  • FIG. 20 Orthobiologics market: Application movement analysis
  • FIG. 21 Global spinal fusion market, 2014 - 2025 (USD Billion)
  • FIG. 22 Global trauma repair market, 2014 - 2025 (USD Billion)
  • FIG. 23 Global reconstructive surgery market, 2014 - 2025 (USD Billion)
  • FIG. 24 Orthobiologics market end-use outlook: Key takeaways
  • FIG. 25 Orthobiologics market: End-use movement analysis
  • FIG. 26 Global hospitals market, 2014 - 2025 (USD Billion)
  • FIG. 27 Global orthopedic clinics market, 2014 - 2025 (USD Billion)
  • FIG. 28 Regional market place: Key takeaways
  • FIG. 29 Regional outlook, 2015 & 2024
  • FIG. 30 North America orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 31 U.S. orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 32 Canada orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 33 Europe orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 34 Germany orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 35 UK orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 36 Asia Pacific orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 37 Japan orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 38 China orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 39 India orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 40 Latin America orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 41 Brazil orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 42 Mexico orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 43 MEA orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 44 South Africa orthobiologics market, 2014 - 2025 (USD Billion)
  • FIG. 45 Strategy framework
  • FIG. 46 Participant categorization
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research